Terminal Illness V. Opportunistic Infections Table 5-5. TMP-SMX is now considered inadequate for empiric use due to high rates of resistance. This report has led to controversy regarding the recommendation for Pneumovax for HIV-infected persons. May require life-long therapy. H. influenzae vaccine is not recommended for adults because most infections involve non-encapsulated strains that are not covered by the vaccine.
Antibiotic selection requires in vitro susceptibility data.
1 month or until infiltrate clears. Resistance to these agents may develop. Eradication of Salmonella has been demonstrated only for ciprofloxacin. AZT is active vs most Salmonella strains and may be effective prophylaxis. Drug selection requires in vitro susceptibility data, especially for ampicillin.